Dr Moulinath Banerjee

Consultant, Diabetes and Endocrinology

Professional background

  • Postgraduate certificate in Medical Education, Edge Hill University, Merit, 2014
  • FRCP, Edinburgh, 2012
  • CCT: Diabetes, Endocrinology & General Medicine, NW Deanery, Completed, 2009
  • PhD, Manchester University, Pass, 2008
  • MRCP, RCP(UK), Pass, 1999
  • MD, Berhampur University, Pass, 1996
  • MBBS, Kolkata University, Pass, 1992

Dr Banerjee came to work at Bolton NHS Foundation Trust in March 2015, having previously worked at Wirral University Teaching Hospitals NHS Foundation Trust, Cumbria Partnership NHS Foundation Trust, Bolton PCT, North-West Deanery, Manchester University, All-Wales Deanery and Burnley NHS Trust.

Professional membership

  • Diabetes UK
  • Society for Endocrinology
  • Association of British Clinical Diabetologists
  • Artery Society
  • National Osteoporosis Society
  • Diabetes and Obesity Research Network
  • Fellow of Royal College of Physicians of Edinburgh
  • British Medical Association
  • Medical Defence Union

Dr Banerjee is an Honorary Clinical Lecturer in Centre for the Endocrinology and Diabetes Research Group at the University of Manchester.

Special interests and research

  • Medical disorders in pregnancy
  • Insulin pump and other technology usage in managing diabetes
  • Medical education
  • Hypertension and calcium and bone metabolism
  • Cardiovascular disease in patients with pre-diabetes

Accolades

  • Poster award at Joint British Endocrine Societies meeting, 2008
  • Recipient of BHF-PhD fellowship in 2003.
  • Best Paper Award in Annual Conference of Association of Physicians of India-1997.
  • Gold medal in Forensic Medicine (1988-89).

Publications

Published articles:

Potential Mechanism of SGLT2i Induced Euglycaemic Diabetic Ketoacidosis Banerjee M Endocrinol Diabetes Res 2015, 1:2 ttp://dx.doi.org/10.4172/ecdr.1000107 (In press).

Anderson SG, Dunn WB, Banerjee M, Brown M, Broadhurst DI, Goodacre R, Cooper GJ, Kell DB, Cruickshank JK. Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes. PLoS One. 2014 Sep 3;9(9):e103217. doi: 10.1371/journal.pone.0103217.

Banerjee M, White A, Pearson R, et al. Screening for cardiovascular risk factors in patients admitted for acute coronary syndrome. Int J Clin Pract. 2014;68:929-30.

Banerjee M, Macdougall M, Lakhdar AF Impact of a single one-to-one education session on glycaemic control in patients with diabetes. Journal of Diabetes. 2012;4:186-90.

Banerjee M, Anderson SG, Malik RA, Austin CE, Cruickshank JK. Small artery function 2 years postpartum in women with altered glycaemic distributions in their preceding pregnancy. Clin Sci (Lond). 2012;122:53-61.

Paisley AN, Banerjee M, Rezai M, Schofield RE, Balakrishnannair S, Herbert A, Lawrance JA, Trainer PJ, Cruickshank JK Changes in arterial stiffness but not carotid intimal thickness in acromegaly. J Clin Endocrinol Metab. 2011;96:1486-92.

Banerjee M, Bhattacharya A, Hughes SM, Vice PA. Efficacy of insulin lispro in pregnancies complicated with pregestational diabetes mellitus. Practical Diabetes International 2009; 26:366-370.

Banerjee M, Humphreys J, Wheatland V, and Vice PA. Photobiomodulation therapy for diabetic foot ulcers, The Diabetic Foot Journal. 2009; 12(2): 46-49.

Koudsi, A., Oldroyd, J., McElduff, P., Banerjee, M., Vyas, A., & Cruickshank, J. K., “Maternal and Neonatal Influences on, and Reproducibility of, Neonatal Aortic Pulse Wave Velocity”, Hypertension 2006;01-04.

Published reviews:

Banerjee M, Younis N, Soran H. Vildagliptin in clinical practice: a review of literature. Expert Opinion in Pharmacotherapy. 2009; 10:2745-57.

Banerjee M, Cruickshank JK. Pregnancy as the prodrome to vascular dysfunction and cardiovascular risk. Nature Clinical Practice Cardiovascular Medicine. 2006; 3:596-603.

Oldroyd J, Banerjee M, Heald A, Cruickshank K. Diabetes and ethnic minorities. Postgraduate Medical Journal. 2005; 81:486-90.

Published editorials:

Cruickshank JK, Banerjee M. Pregnancy glycaemia to vascular risk: nonglycaemic diabetes? Canadian Medical Association Journal. 2009 15; 181:361-2.

Banerjee M. Vyas A. Cruickshank JK. Ethnicity and its implications in diabetes management. Practical Diabetes International. 2004; 21:135-137.

Published case reports:

Cooksley T, Banerjee M, Younis N. Metastatic breast carcinoma presenting with profound hypocalcaemia. South Med J. 2010 May; 103:480-1.

Published book chapters:

C Allan, M Banerjee, FC Wu. Testosterone and Coronary heart disease. Endotext.com Chapter 16. January 2011.

JK Cruickshank, A Vyas, M Banerjee, JC Oldroyd. Coronary heart disease in South Asians: the impact of type 2 diabetes mellitus. The epidemic of coronary heart disease in South Asian populations: causes and consequences. Ed. KCR Patel, RS Bhopal. 2004:3:48-61.

M.Banerjee, JK Cruickshank. Hypertension and diabetes: ethnicity and treatment. Diabetes and Hypertension Ed. CE Mogensen 2003; 3: 45-60.

Dr Moulinath Banerjee

Consultant, Diabetes and Endocrinology

Contact Number

01204 390583

Dr Moulinath Banerjee works in the following services:

Skip to content